Pinnacle Bancorp, Inc. Bristol Myers Squibb CO Transaction History

Pinnacle Bancorp, Inc.

$318 Million
Q2 2025

A detailed history of Pinnacle Bancorp, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pinnacle Bancorp, Inc. holds 2,789 shares of BMY stock, worth $129,827. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,789

Previous 2,889 3.46%

Holding current value

$129,827

Previous $176,000 26.7%

% of portfolio

0.04%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	SELL	$44.12 - $59.6 $4,412 - $5,960	-100 Reduced 3.46%	2,789 $129,000
Q1 2025 Apr 23, 2025	SELL	$53.9 - $63.11 $15,469 - $18,112	-287 Reduced 9.04%	2,889 $176,000
Q4 2024 Jan 14, 2025	BUY	$51.92 - $59.94 $31,152 - $35,964	600 Added 23.29%	3,176 $179,000
Q2 2024 Jul 15, 2024	SELL	$40.25 - $52.99 $30,187 - $39,742	-750 Reduced 22.55%	2,576 $106,000
Q1 2024 Apr 16, 2024	BUY	$47.98 - $54.4 $27,108 - $30,736	565 Added 20.46%	3,326 $180,000
Q4 2023 Jan 25, 2024	BUY	$48.48 - $57.85 $11,974 - $14,288	247 Added 9.82%	2,761 $141,000
Q3 2023 Oct 18, 2023	SELL	$57.89 - $64.73 $54,995 - $61,493	-950 Reduced 27.42%	2,514 $145,000
Q2 2023 Jul 13, 2023	BUY	$63.71 - $70.74 $6,371 - $7,073	100 Added 2.97%	3,464 $221,000
Q4 2022 Jan 24, 2023	BUY	$68.48 - $81.09 $3,766 - $4,459	55 Added 1.66%	3,364 $242,000
Q3 2022 Oct 25, 2022	SELL	$0.13 - $76.84 $13 - $7,837	-102 Reduced 2.99%	3,309 $235,000
Q2 2022 Jul 12, 2022	BUY	$72.62 - $79.98 $103,773 - $114,291	1,429 Added 72.1%	3,411 $263,000
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $8,976 - $10,763	146 Added 7.95%	1,982 $145,000
Q3 2021 Oct 12, 2021	BUY	$59.17 - $69.31 $10,295 - $12,059	174 Added 10.47%	1,836 $109,000
Q2 2021 Jul 15, 2021	SELL	$61.91 - $67.42 $13,558 - $14,764	-219 Reduced 11.64%	1,662 $111,000
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $2,670 - $3,003	-45 Reduced 2.34%	1,881 $119,000
Q3 2020 Oct 13, 2020	SELL	$57.43 - $63.64 $10,624 - $11,773	-185 Reduced 8.76%	1,926 $116,000
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $30,756 - $40,118	625 Added 42.06%	2,111 $136,000
Q3 2019 Oct 08, 2019	SELL	$42.77 - $50.71 $22,325 - $26,470	-522 Reduced 26.0%	1,486 $75,000
Q2 2019 Jul 08, 2019	SELL	$44.62 - $49.34 $4,462 - $4,934	-100 Reduced 4.74%	2,008 $91,000
Q1 2019 Apr 05, 2019	SELL	$45.12 - $53.8 $27,478 - $32,764	-609 Reduced 22.41%	2,108 $101,000
Q4 2018 Mar 20, 2019	BUY	$48.76 - $63.23 $132,480 - $171,795	2,717 New	2,717 $141,000

Others Institutions Holding BMY

# of Institutions

2,673

Shares Held

1.64B

Call Options Held

24.2M

Put Options Held

28M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.

Account

Pinnacle Bancorp, Inc. Bristol Myers Squibb CO Transaction History